Peregrine Capital Management LLC Chemo Centryx, Inc. Transaction History

Peregrine Capital Management LLC

$3.18 Billion
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 03, 2021	SELL	$9.59 - $50.88 $1.73 Million - $9.2 Million	-180,816 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$49.53 - $68.4 $1.25 Million - $1.72 Million	-25,179 Reduced 12.22%	180,816 $9.27 Million
Q4 2020 Jan 19, 2021	BUY	$47.25 - $65.16 $885,984 - $1.22 Million	18,751 Added 10.01%	205,995 $12.8 Million
Q3 2020 Oct 20, 2020	BUY	$46.35 - $61.69 $8.68 Million - $11.6 Million	187,244 New	187,244 $10.3 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.